Tag: Pharmaceuticals

Here are some of the major companies whose stocks moved on the week’s news.

Amgen has a couple of shots on goal to break into one of the biggest markets the pharmaceutical industry has ...

What to Read Next

Pentwater Capital predicted that FTC efforts to block big deals would fail.

Wall Street should pay attention as the pharma industry mounts a widening legal campaign against the Inflation Reduction Act.

VinFast, the Vietnamese electric-vehicle maker, and Arm, a British chip designer, are caught in a weird limbo thanks to their ...

The decision to buy Reata signals a new era under CEO Chris Viehbacher, and Wall Street’s skepticism presents an opportunity.

Shares of Recursion Pharmaceuticals, Schrodinger and others that are implementing AI are surging.

Biogen, Eli Lilly drugs will expand the imaging market for companies in the diagnostics space.

The activist is pushing for a shake-up of the contract drug manufacturer’s board.